Stay updated on Adagrasib Combo Therapies in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo Therapies in Advanced NSCLC Clinical Trial page.

Latest updates to the Adagrasib Combo Therapies in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check8 days agoChange DetectedA sitewide NIH notice announces website-transition updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.5%

- Check15 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check22 days agoChange DetectedThe site's revision indicator changes from v3.7.0 to v3.7.1. The study record history remains unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now shows a new revision entry v3.7.0 added to the history, and the previous v3.6.6 entry is removed from the list.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new revision entry v3.6.6 and removed the previous v3.6.5 from the study history log, updating the page's revision history to reflect the latest version.SummaryDifference0.1%

Stay in the know with updates to Adagrasib Combo Therapies in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo Therapies in Advanced NSCLC Clinical Trial page.